HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhogal, N. Articles by Findlay, J. B. Search for Related Content PubMed PubMed Citation Articles by Bhogal, N. Articles by Findlay, J. B. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 44, 27269-27274, 11, 1994

The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor

N Bhogal, D Donnelly and JB Findlay
Department of Biochemistry and Molecular Biology, University of Leeds, United Kingdom.

Thirteen residues in the human neurokinin 2 (NK2) receptor were identified as potential ligand-binding residues by molecular modeling and amino acid sequence analysis. Site-directed mutagenesis was used to alter these residues in order to ascertain their importance in binding neurokinin A (NKA), the physiological peptide ligand for the NK2 receptor, and the non-peptide NK2 receptor selective antagonist SR48968. Four sites appear to be critical for NKA binding (Gln109, His198, Ile202, and Gly273). The mutant receptors Gln109-->His, Ile202-- >Val, Gly273-->Pro, and Gly273-->Thr maintain their affinity for SR48968, despite being unable to bind the peptide ligand. His198-->Ala and His198-->Leu no longer bind NKA or SR48968. We have also identified a residue (Leu292) which appears to play a minor role in the binding of substance P (SP) and neurokinin B (NKB) to the NK2 receptor. The mutant receptor Leu292-->Ser binds NKB and SP with approximately a 5-fold greater affinity in comparison with the wild type receptor while the affinity of NKA remains unaffected. The results suggest that intramembranous residues, as well as residues which lie close to the extracellular side of transmembrane helices 3, 5, and 6, form part of the NK2 receptor binding site. Binding of SP and NKB to the NK2 receptor may also be influenced by residues near the extracellular side of helix 7. These results suggest that some regions of the binding site for NKA in the NK2 receptor are not used for binding SP in the NK1 receptor. However, it also seems that the NKA binding site includes regions that are also used by other G-protein-coupled receptors such as rhodopsin and the beta 2-adrenergic receptors.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Mamputha, Z.-l. Lu, R. W. Roeske, R. P. Millar, A. A. Katz, and C. A. Flanagan Conserved Amino Acid Residues that Are Important for Ligand Binding in the Type I Gonadotropin-Releasing Hormone (GnRH) Receptor Are Required for High Potency of GnRH II at the Type II GnRH Receptor Mol. Endocrinol., January 1, 2007; 21(1): 281 - 292. [Abstract] [Full Text] [PDF]

				I. R. Chandrashekar and S. M. Cowsik Three-Dimensional Structure of the Mammalian Tachykinin Peptide Neurokinin A Bound to Lipid Micelles Biophys. J., December 1, 2003; 85(6): 4002 - 4011. [Abstract] [Full Text] [PDF]

				J. A. Ballesteros, L. Shi, and J. A. Javitch Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors Mol. Pharmacol., July 1, 2001; 60(1): 1 - 19. [Abstract] [Full Text]

				U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text]

				S. Barroso, F. Richard, D. Nicolas-Etheve, J.-L. Reversat, J.-M. Bernassau, P. Kitabgi, and C. Labbe-Jullie Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1 J. Biol. Chem., January 7, 2000; 275(1): 328 - 336. [Abstract] [Full Text] [PDF]

				X.-P. Huang, F. E. Williams, S. M. Peseckis, and W. S. Messer Jr. Differential Modulation of Agonist Potency and Receptor Coupling by Mutations of Ser388Tyr and Thr389Pro at the Junction of Transmembrane Domain VI and the Third Extracellular Loop of Human M1 Muscarinic Acetylcholine Receptors Mol. Pharmacol., October 1, 1999; 56(4): 775 - 783. [Abstract] [Full Text]

				A. R. Renzetti, R.-M. Catalioto, M. Criscuoli, P. Cucchi, C. Ferrer, A. Giolitti, M. Guelfi, L. Rotondaro, F. J. Warner, and C. A. Maggi Relevance of Aromatic Residues in Transmembrane Segments V to VII for Binding of Peptide and Nonpeptide Antagonists to the Human Tachykinin NK2 Receptor J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 487 - 495. [Abstract] [Full Text]

				C. Labbe-Jullie, S. Barroso, D. Nicolas-Eteve, J.-L. Reversat, J.-M. Botto, J. Mazella, J.-M. Bernassau, and P. Kitabgi Mutagenesis and Modeling of the Neurotensin Receptor NTR1. IDENTIFICATION OF RESIDUES THAT ARE CRITICAL FOR BINDING SR 48692, A NONPEPTIDE NEUROTENSIN ANTAGONIST J. Biol. Chem., June 26, 1998; 273(26): 16351 - 16357. [Abstract] [Full Text] [PDF]

				S. C. Sealfon, H. Weinstein, and R. P. Millar Molecular Mechanisms of Ligand Interaction with the Gonadotropin-Releasing Hormone Receptor Endocr. Rev., April 1, 1997; 18(2): 180 - 205. [Abstract] [Full Text]

				K. Nemeth and A. Chollet A Single Mutation of the Neurokinin-2 (NK2) Receptor Prevents Agonist-induced Desensitization J. Biol. Chem., November 17, 1995; 270(46): 27601 - 27605. [Abstract] [Full Text] [PDF]

				N. E. Labrou, N. Bhogal, C. R. Hurrell, and J. B. C. Findlay Interaction of Met297 in the Seventh Transmembrane Segment of the Tachykinin NK2 Receptor with Neurokinin A J. Biol. Chem., October 5, 2001; 276(41): 37944 - 37949. [Abstract] [Full Text] [PDF]